Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide
- 1 June 2004
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 100 (6) , 1060-1065
- https://doi.org/10.3171/jns.2004.100.6.1060
Abstract
Object. The Chk1 and p38 mitogen-activated protein kinase (MAPK) pathways play key roles in the G2 arrest caused by exposing glioma cells to temozolomide (TMZ). Although inhibition of either pathway sensitizes glioma cells to TMZ-induced cytotoxicity, the relative contributions of these pathways to TMZ-induced G2 arrest and to TMZ resistance conferred by G2 arrest have not been defined. Methods. The authors pharmacologically inhibited the Chk1 and/or p38 pathways in U87MG human glioma cells prior to and/or after exposure to TMZ; thereafter, effects on the TMZ-induced G2 arrest pathway and toxicity were monitored. The p38 inhibitor SB203580 or the Chk1 inhibitor UCN-01 or their combination blocked TMZ-mediated inactivation of cdc25C and cdc2, suggesting that p38 and Chk1 pathways work cooperatively and are both necessary to inactivate cdc25C and cdc2. Consistent with this idea, the inhibition of both Chk1 and p38 pathways did not lead to greater bypass of TMZ-induced G2 arrest or greater cytotoxicity than ...Keywords
This publication has 20 references indexed in Scilit:
- The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating AgentsMolecular and Cellular Biology, 2003
- Delayed repletion of O6-methylguanine—DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicityJournal of Neurosurgery, 2003
- Novel small molecule cyclin-dependent kinases modulators in human clinical trials.Cancer Biology & Therapy, 2003
- Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA DamageMolecular and Cellular Biology, 2002
- A Role for PI 3-Kinase and PKB Activity in the G2/M Phase of the Cell CycleCurrent Biology, 2002
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and Its Interaction with DNABiochemistry, 1994
- An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.Proceedings of the National Academy of Sciences, 1993
- Self-destruction and tolerance in resistance of mammalian cells to alkylation damageNucleic Acids Research, 1992
- Mismatch correction at O6-methylguanine residues in E. coli DNANature, 1982